Previous 10 | Next 10 |
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Application (NDA) for TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL, a synthetic corticosteroid indicated for the treatmen...
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the following two upcoming conferences: BTIG 3 rd Annual Ophthalmology Day Format: Fi...
2023-11-17 14:58:48 ET Summary Strategies for generating passive income include income investing, real estate investment trusts, master limited partnerships, exchange-traded debt, bonds, value-add property, joint ventures/REITs, and peer-to-peer lending. Preferred stocks, REITs, M...
ATLANTA, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Harrow, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW) complied with federal securities laws. On November 13, 2023, Harrow released its third quarter 2023 financial results re...
2023-11-15 00:33:34 ET Summary Harrow is a company focused on eye health with a strong distribution platform and CEO ownership. Q3 earnings were below expectations, and guidance was lowered, raising concerns about operational performance. However, the company has lots of oppor...
2023-11-14 14:22:16 ET Gainers: BioCardia ( BCDA ) +170% . reAlpha Tech Corp. ( AIRE ) +119% . Turnstone Biologics Corp ( TSBX ) +75% . Theseus Pharmaceuticals ( THRX ) +49% . American Coastal Insurance Corp ( ACIC ) +38% . M...
2023-11-14 13:31:57 ET More on Harrow Health Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript Implications Of Harrow's Short-Term Guidance Harrow Health's 5-Year Guidance Biggest stock movers today: Home Depot, Fisker, Snap, Beauty Health Company and more...
2023-11-14 08:10:54 ET More on pre-market losers Financial information for Collective Audience, Inc. Financial information for E-Home Household For further details see: EJH and CAUD among pre-market losers
2023-11-14 05:00:20 ET Related stories: The Beauty Health Company (SKIN) Q3 2023 Earnings Call Transcript Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript Fisker, Inc. (FSR) Q3 2023 Earnings Call Transcript For further details see: Biggest stock mover...
2023-11-13 21:25:23 ET Harrow, Inc. (HROW) Q3 2023 Earnings Conference Call November 13, 2023 16:45 ET Corporate Participants Jamie Webb - Director-Communications & Investor Relations Mark Baum - Chief Executive Officer Andrew Boll - Chief Financial Officer ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-21 10:00:07 ET Chase Knickerbocker from Craig-Hallum issued a price target of $30.00 for HROW on 2024-06-21 08:28:00. The adjusted price target was set to $30.00. At the time of the announcement, HROW was trading at $19.93. The overall price target consensus is a...
Harrow Health, Inc. (NASDAQ: HROW) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 13.77% on the day to $20.08. Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an op...